Skip to main content
. Author manuscript; available in PMC: 2011 Nov 1.
Published in final edited form as: Cancer Res. 2010 Oct 12;70(21):8487–8497. doi: 10.1158/0008-5472.CAN-10-1013

Figure 4.

Figure 4

(A) WHSC1L1 expression in SUM-44 cells was analyzed by semiquantitative RT-PCR and western blot after infection with non-silencing control shRNA or WHSC1L1 specific shRNA (shRNA#2 and #6). (B). The images showed the TurboGFP fluorescence of pGIPZ-WHSC1L1 shRNAs in SUM-44 cells after 3 weeks. (C) shRNA-mediated knock-down of WHSC1L1 inhibits cell growth in breast cancer cells SUM-44 and SUM-52 with WHSC1L1 amplification.